Proshares UltraPro Nasdaq Biotechnology (UBIO) Declined -5.05% or -2.01 To Price $37.77 On Wednesday


Proshares UltraPro Nasdaq Biotechnology (UBIO) declined -5.05% or -2.01 to $37.77. It is around 45249 shares traded, which is 113.76% compare to the average total volume 39775. The market cap of UBIO is $33.99 million. The year to date change is 5.08%. The 52 week price range is from $25.8 to $46.35. Price of UBIO have changed -0.87% during last week. It have changed -1.66% over last month, 25.53% over last 3 months, 12.69% over last 6 months and 27.42% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for UBIO is 37.45. It is -0.85% below current price. The stock is at support level of 50-day moving averages. The 200-day Moving Averages for UBIO is 34.38. It is -8.98% below current price. The 52-week High is 46.35. It is 22.72% from the current price. The 52-week Low is 25.8. It is -31.69% from current price.

There are some statistics of UBIO. It is has market cap $33.99 million. The share outstanding is 899915. The average volume is 39775. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of UBIO is 4.39%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of UBIO is -4.02%.


Tags:

Share this post